These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 24795255)

  • 1. Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease.
    de Vries AP; Ruggenenti P; Ruan XZ; Praga M; Cruzado JM; Bajema IM; D'Agati VD; Lamb HJ; Pongrac Barlovic D; Hojs R; Abbate M; Rodriquez R; Mogensen CE; Porrini E;
    Lancet Diabetes Endocrinol; 2014 May; 2(5):417-26. PubMed ID: 24795255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function.
    Guebre-Egziabher F; Alix PM; Koppe L; Pelletier CC; Kalbacher E; Fouque D; Soulage CO
    Biochimie; 2013 Nov; 95(11):1971-9. PubMed ID: 23896376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overweight, obesity and metabolic alterations in chronic kidney disease.
    Zoccali C
    Prilozi; 2009 Dec; 30(2):17-31. PubMed ID: 20087247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice.
    Yang P; Xiao Y; Luo X; Zhao Y; Zhao L; Wang Y; Wu T; Wei L; Chen Y
    J Lipid Res; 2017 Jul; 58(7):1417-1427. PubMed ID: 28536108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Obesity-related glomerulopathy: Mechanisms of development, clinical course].
    Kutyrina IM
    Ter Arkh; 2017; 89(6):97-101. PubMed ID: 28745696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Obesity and chronic kidney disease].
    Bondar' IA; Klimontov VV; Simakova AI
    Ter Arkh; 2011; 83(6):66-70. PubMed ID: 21786579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity-Related Glomerulopathy: A Latent Change in Obesity Requiring More Attention.
    Yang S; Cao C; Deng T; Zhou Z
    Kidney Blood Press Res; 2020; 45(4):510-522. PubMed ID: 32498064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid Accumulation and Chronic Kidney Disease.
    Gai Z; Wang T; Visentin M; Kullak-Ublick GA; Fu X; Wang Z
    Nutrients; 2019 Mar; 11(4):. PubMed ID: 30925738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.
    D'Agati VD; Chagnac A; de Vries AP; Levi M; Porrini E; Herman-Edelstein M; Praga M
    Nat Rev Nephrol; 2016 Aug; 12(8):453-71. PubMed ID: 27263398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of obesity and chronic kidney disease.
    Ross WR; McGill JB
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):325-35. PubMed ID: 17045219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis.
    Darouich S; Goucha R; Jaafoura MH; Zekri S; Ben Maiz H; Kheder A
    Ultrastruct Pathol; 2011 Aug; 35(4):176-82. PubMed ID: 21657818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural renal changes in obesity and diabetes.
    Amann K; Benz K
    Semin Nephrol; 2013 Jan; 33(1):23-33. PubMed ID: 23374891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low glomerular density with glomerulomegaly in obesity-related glomerulopathy.
    Tsuboi N; Utsunomiya Y; Kanzaki G; Koike K; Ikegami M; Kawamura T; Hosoya T
    Clin J Am Soc Nephrol; 2012 May; 7(5):735-41. PubMed ID: 22403274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renal consequences of obesity].
    Laville M
    Nephrol Ther; 2011 Apr; 7(2):80-5. PubMed ID: 21208837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.
    Wahba IM; Mak RH
    Clin J Am Soc Nephrol; 2007 May; 2(3):550-62. PubMed ID: 17699463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte lesions in patients with obesity-related glomerulopathy.
    Chen HM; Liu ZH; Zeng CH; Li SJ; Wang QW; Li LS
    Am J Kidney Dis; 2006 Nov; 48(5):772-9. PubMed ID: 17059996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid mediators of inflammation in obesity-related glomerulopathy.
    Nolan E; O'Meara YM; Godson C
    Nephrol Dial Transplant; 2013 Nov; 28 Suppl 4():iv22-9. PubMed ID: 24081855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Overweight and obesity--risk factors in the development and progression of renal disease].
    Sebeková K; Klassen A; Bahner U; Heidland A
    Vnitr Lek; 2004 Jul; 50(7):544-9. PubMed ID: 15323263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal disease in obesity: the need for greater attention.
    Rutkowski P; Klassen A; Sebekova K; Bahner U; Heidland A
    J Ren Nutr; 2006 Jul; 16(3):216-23. PubMed ID: 16825023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and kidney disease.
    Silva Junior GB; Bentes AC; Daher EF; Matos SM
    J Bras Nefrol; 2017 Mar; 39(1):65-69. PubMed ID: 28355395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.